Remco Munnik, Arcana, details pharma's shift to data-first operations, AI adoption, and robust data stewardship.

Shanghai Pharmaceuticals Holding Co ( ($HK:2607) ) has shared an update. Shanghai Pharmaceuticals announced the completion of an equity adjustment ...

Ultimately, these advancements suggest a more integrated ecosystem. Trusted regulatory spaces function like a communal ...

DUBLIN--(BUSINESS WIRE)--The "MBA Strategic Thinking for Pharma and Biopharma Professionals Training Course (Feb 23rd - Feb 24th, 2026)" training has been added to ResearchAndMarkets.com's offering.

Large pharmaceutical companies are entering a period of renewed relevance as therapeutic innovation accelerates, particularly ...

The combined Company will move forward as Decoy Therapeutics, Inc. and trade on the NASDAQ Stock Market under the ticker 'DCOY” effective in early January 2026 ...

For cell therapy manufacturers such as Kite Pharma where every product is made for a single patient, labeling becomes a ...

Nivin Pauly makes a strong comeback with Pharma, a slick thriller on the pharmaceutical world. The series explores corporate ...

GLP-1 medicines have been utilised for the treatment of diabetes; however, they are now emerging as important topics for the treatment of obesity ...

Policy initiatives have come fast and furious at the FDA this year. While guidances on rare diseases and vaccines have consumed most of the ink, policy shifts aimed at improving FDA efficiencies and ...

Industry Report Examines What Consumers Are Searching For After Seeing Weight Loss Patch Ads, What These Products Actually ...

Fintel reports that on December 19, 2025, Citizens maintained coverage of Mirum Pharmaceuticals (NasdaqGM:MIRM) with a Market Outperform recommendation. Analyst Price Forecast Suggests 15.46% Upside ...